Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2349)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (100)
  6. Guidelines (39)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (22)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4744)
  2. Department of Medicine (4742)
  3. Center for Pancreatic Cancer Research (2312)
  4. Surgery (1065)
  5. Survivorship Research (1013)
  6. Epidemiology and Biostatistics (842)

More Groups

People
  1. Eileen O'Reilly (803)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (219)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (147)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (320)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4744)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • FRONTIER: FAPi Radioligand OpeN-label, phase 1 study to evaluate safety, Tolerability and dosImetry of [Lu-177]-PNT6555; a dose Escalation study for tReatment of patients with select solid tumors
    Meeting Abstract

    Juneau, D.; Kavan, P.; Metser, U.; Abikhzer, G.; Bodei, L.; Liberman, M.; Taunk, N.; O'Reilly, E. M.; Ma, J. S.; Cioci, R.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Dose escalation and curative therapy of colorectal cancer with anti-GPA33 self-assembling and disassembling (SADA) actinium-225 alpha pretargeted radioimmunotherapy
    Meeting Abstract

    Aguirre, N.; Veach, D.; Guo, H. F.; Espinosa-Cotton, M.; Fung, E.; Xu, H.; Feng, Y.; Leung, K.; Cheung, I.; Carrasco, S.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Multiplex imaging of the immune microenvironment after intratumoral immunotherapy
    Meeting Abstract

    Garcia, J.; Garcia, J.; Gomez, R.; Vistain, L.; Khalil, D.; Germain, R.; Maltez, V.
    Journal of Immunology (2024)

    Fulltext@MSK | Save
  • Does radiation boost dose affect organ preservation rates? A secondary analysis of the OPRA trial
    Meeting Abstract

    Yariv, O.; Williams, H.; Goodman, K. A.; Verheij, F. S.; Omer, D. M.; Lin, S. T.; Qin, L. X.; Gollub, M. J.; Saltz, L.; Garcia-Aguilar, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Radiation quality control in the PROSPECT trial
    Meeting Abstract

    Mamon, H. J.; Shi, Q.; Smith, K. S.; Colgrove, B.; Quigley, J.; Nelson, G.; Weiser, M.; Gollub, M. J.; Saltz, L.; Basch, E.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Multi-institutional comparison of ablative 5-fraction MR-guided online adapted vs. 15/25-fraction CT-guided offline adapted radiation therapy for locally advanced pancreas cancer
    Meeting Abstract

    Chuong, M. D.; O'Reilly, E.; Herrera, R.; Zinovoy, M.; Mittauer, K. E.; Rubens, M.; Romesser, P. B.; Wu, A. J.; Bassiri-Gharb, N.; Hajj, C.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Alliance A022101/NRG-G1009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer evaluating radiation, ablation and surgery (ERASur)
    Meeting Abstract

    Romesser, P. B.; Miller, E. D.; Shi, Q.; Dixon, J. G.; Gholami, S.; White, S.; Wu, C.; Goulet, C. C.; Jee, K. W.; Wright, C.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Clinicogenomic predictors of survival and intracranial progression after stereotactic radiosurgery for colorectal cancer brain metastases
    Meeting Abstract

    Gui, C.; Walch, H.; Mueller, K.; Boe, L. A.; Ilica, A. T.; Strong, J.; Eichholz, J.; Yu, K.; Wilcox, J. A.; Manca, P.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Updated safety and efficacy from a phase 1 study of RMC-6236, a RAS (ON) multi-selective, tri-complex inhibitor, in patients with RAS mutant pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Wolpin, B.; Hong, D.; Spira, A.; Starodub, A.; Park, W.; Sommerhalder, D.; Valerin, J.; Barve, M.; Punekar, S.; Pelster, M.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Advancing global health equity in oncology clinical trial access
    Editorial

    Bloomberg New Economy International Cancer Coalition; McKinsey Cancer Center; Cure4Cancer
    Cancer Discovery (2024)

    Fulltext@MSK | Save